US Patent 7767211 None
Patent 7767211 was granted and assigned to Absynth Biologics on August, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+259 characters)
Article
Patent abstract
The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Jorge Garcia-Lara0
Simon J. Foster0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07767211 None US Patent 7767211 None
Infobox
Patent Number
077672110
Patent Number
77672110
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077672110
Date of Patent
August 3, 2010
0Patent Application Number
119092580
Date Filed
March 8, 2006
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07767211 None
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07767211
Date of patent
August 3, 2010
Patent application number
11909258
Date Filed
March 8, 2006
Patent primary examiner
Find more entities like US Patent 7767211 None
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
